Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Huber

Showing results (401-410 of 431) with videos related to

Pageof 44
Sort By:
Assay and Drug Development Technologies|May 22, 2014
A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyaseMohammed A Kashem, Chunling Wa, John P Wolak, et al.
Nature Genetics|June 25, 2013
Massive genomic variation and strong selection in Arabidopsis thaliana lines from SwedenQuan Long, Fernando A Rabanal, Dazhe Meng, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
Msphere|April 20, 2018
The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected CellsAndrew D Huber, Jennifer J Wolf, Dandan Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 13, 2014
Ischemic stroke injury is mediated by aberrant Cdk5Douglas A Meyer, Melissa I Torres-Altoro, Zhenjun Tan, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse TranscriptaseKaren A Kirby, Nataliya A Myshakina, Martin T Christen, et al.
ACS Infectious Diseases|December 25, 2018
Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral CoresAndrew D Huber, Dallas L Pineda, Dandan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108Paul M Barr, Hongli Li, Catherine Spier, et al.
Journal of Medicinal Chemistry|July 19, 2012
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the ratJohn D Huber, Jörg Bentzien, Stephen J Boyer, et al.
Pageof 44

Showing results (401-410 of 431) with videos related to

Sort By:
Pageof 44
Assay and Drug Development Technologies|May 22, 2014
A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyaseMohammed A Kashem, Chunling Wa, John P Wolak, et al.
Nature Genetics|June 25, 2013
Massive genomic variation and strong selection in Arabidopsis thaliana lines from SwedenQuan Long, Fernando A Rabanal, Dazhe Meng, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease HAndrew D Huber, Eleftherios Michailidis, Jing Tang, et al.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
Msphere|April 20, 2018
The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected CellsAndrew D Huber, Jennifer J Wolf, Dandan Liu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 13, 2014
Ischemic stroke injury is mediated by aberrant Cdk5Douglas A Meyer, Melissa I Torres-Altoro, Zhenjun Tan, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse TranscriptaseKaren A Kirby, Nataliya A Myshakina, Martin T Christen, et al.
ACS Infectious Diseases|December 25, 2018
Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral CoresAndrew D Huber, Dallas L Pineda, Dandan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108Paul M Barr, Hongli Li, Catherine Spier, et al.
Journal of Medicinal Chemistry|July 19, 2012
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the ratJohn D Huber, Jörg Bentzien, Stephen J Boyer, et al.
Pageof 44